Prognostic value of baseline MRI features in patients treated with thermal ablation for hepatocellular carcinoma

被引：2
|
作者：
Oecal, Osman [1 ]
Schuette, Kerstin [2 ]
Malfertheiner, Peter [3 ]
Berg, Thomas [4 ]
Loewe, Christian [5 ]
Klumpen, Heinz Josef [6 ]
Zech, Christoph Johannes [7 ]
van Delden, Otto [8 ]
Uemuetlue, Muzaffer Reha [1 ]
Deniz, Sinan [1 ]
Ben Khaled, Najib [3 ]
De Toni, Enrico Narciso [3 ]
Hoang, Thi Phuong Thao [1 ]
Seidensticker, Ricarda [1 ]
Aghdassi, Ali [9 ]
Pech, Maciej [10 ]
Ricke, Jens [1 ]
Seidensticker, Max [1 ,11 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany
[2] Niels Stensen Kliniken Marienhosp, Dept Internal Med & Gastroenterol, Osnabruck, Germany
[3] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Med 2, Munich, Germany
[4] Univ Klinikum Leipzig, Klin & Poliklin Gastroenterol, Sekt Hepatol, Leipzig, Germany
[5] Med Univ Vienna, Dept Bioimaging & Image Guided Therapy, Sect Cardiovasc & Intervent Radiol, Vienna, Austria
[6] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Med Oncol, Amsterdam, Netherlands
[7] Univ Basel, Univ Hosp Basel, Radiol & Nucl Med, Basel, Switzerland
[8] Univ Amsterdam, Acad Univ Med Ctr, Dept Radiol & Nucl Med, Amsterdam, Netherlands
[9] Univ Med Greifswald, Dept Med A, D-17489 Greifswald, Germany
[10] Univ Magdeburg, Dept Radiol & Nucl Med, Magdeburg, Germany
[11] Ludwig Maximilian Univ Munich, Univ Hosp, Dept Radiol, Marchioninistr 15, D-81377 Munich, Germany
来源：
EUROPEAN JOURNAL OF RADIOLOGY | 2023年 / 168卷
关键词：
Hepatocellular carcinoma; Local ablation; Time-to-recurrence; Gadoxetic acid; Peritumoral hypointensity; RADIOFREQUENCY ABLATION; SURGICAL RESECTION; CONTROLLED-TRIAL; LIVER RESECTION; DOUBLE-BLIND; RECURRENCE; THERAPY; INTERFERON;
D O I：
10.1016/j.ejrad.2023.111120
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
SORAMIC is an investigator-initiated trial sponsored by the Univer-sity of Magdeburg. Financial support was granted by Sirtex Medical (Woburn, Massachusetts, USA) and Bayer Healthcare (Berlin, Germany).
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Liver resection is superior to tumor ablation in patients with multifocal hepatocellular carcinoma
    Kakish, Hanna
    Suraju, Mohammed O.
    Davis, Erik S.
    Seth, Abhinav
    Kwon, Yong K.
    Aziz, Hassan
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 129 (06) : 1113 - 1120
  • [42] Radio frequency ablation for hepatocellular carcinoma in cirrhotic patients: Prognostic factors for survival
    Guglielmi, Alfredo
    Ruzzenente, Andrea
    Sandri, Marco
    Pachera, Silvia
    Pedrazzani, Corrado
    Tasselli, Sebastiano
    Iacono, Calogero
    JOURNAL OF GASTROINTESTINAL SURGERY, 2007, 11 (02) : 143 - 149
  • [43] Radio Frequency Ablation for Hepatocellular Carcinoma in Cirrhotic Patients: Prognostic Factors for Survival
    Alfredo Guglielmi
    Andrea Ruzzenente
    Marco Sandri
    Silvia Pachera
    Corrado Pedrazzani
    Sebastiano Tasselli
    Calogero Iacono
    Journal of Gastrointestinal Surgery, 2007, 11 : 143 - 149
  • [44] Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib
    Granito, Alessandro
    Marinelli, Sara
    Negrini, Giulia
    Menetti, Saverio
    Benevento, Francesca
    Bolondi, Luigi
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (02): : 240 - 249
  • [45] Classification of hepatocellular carcinoma diameter by statistical technology and prognostic evaluation in patients after the combined use of transarterial chemoembolization and radiofrequency ablation
    Cao, Yanyan
    Ren, Yanqiao
    Ma, Hong
    Zhou, Chen
    Liu, Jiacheng
    Shi, Qin
    Feng, Gansheng
    Zheng, Chuansheng
    Xiong, Bin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (02) : 356 - 364
  • [46] Clinical features of patients with hepatocellular carcinoma treated with radiofrequency ablation therapy: developing a simple score to determine the need for immune-adjuvant therapy
    Tada, Fujimasa
    Hiraoka, Atsushi
    Nakatani, Kosuke
    Matsuoka, Kana
    Fukumoto, Mai
    Matsuda, Takuya
    Yanagihara, Emi
    Saneto, Hironobu
    Murakami, Taisei
    Onishi, Kei
    Izumoto, Hirofumi
    Kitahata, Shogo
    Kanemitsu-Okada, Kozue
    Kawamura, Tomoe
    Kuroda, Taira
    Hanaoka, Jun
    Watanabe, Jota
    Ohtani, Hiromi
    Yoshida, Osamu
    Hirooka, Masashi
    Miyata, Hideki
    Tsubouchi, Eiji
    Abe, Masanori
    Matsuura, Bunzo
    Ninomiya, Tomoyuki
    Hiasa, Yoichi
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (03) : 401 - 411
  • [47] Survival and prognostic factors after transplantation, resection and ablation in a national cohort of early hepatocellular carcinoma
    Eilard, Malin S.
    Naredi, Peter
    Helmersson, Madeleine
    Hemmingsson, Oskar
    Isaksson, Bengt
    Lindell, Gert
    Sandstrom, Per
    Stromberg, Cecilia
    Rizell, Magnus
    HPB, 2021, 23 (03) : 394 - 403
  • [48] Thermal ablation of hepatocellular carcinoma
    Crocetti, Laura
    Lencioni, Riccardo
    CANCER IMAGING, 2008, 8 (01): : 19 - 26
  • [49] Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors
    Ma, Sicong
    Ding, Min
    Li, Jiang
    Wang, Tao
    Qi, Xingxing
    Shi, Yaoping
    Ming, Yanan
    Chi, Jiachang
    Wang, Zhi
    Tang, Xiaoyin
    Cui, Dan
    Zhang, Yuan
    Zhai, Bo
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (01) : 131 - 142
  • [50] Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization
    Lee, Yong Kang
    Kim, Seung Up
    Kim, Do Young
    Ahn, Sang Hoon
    Lee, Kwang Hun
    Lee, Do Yun
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Park, Jun Yong
    BMC CANCER, 2013, 13
12345